Literature DB >> 32066533

Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice.

Richard Beasley1, James Harper2, Matthew Masoli3.   

Abstract

Entities:  

Year:  2020        PMID: 32066533     DOI: 10.1016/S2213-2600(20)30051-5

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  1 in total

Review 1.  Specific Therapy for T2 Asthma.

Authors:  Diego Bagnasco; Elisa Testino; Stefania Nicola; Laura Melissari; Maria Russo; Rikki Frank Canevari; Luisa Brussino; Giovanni Passalacqua
Journal:  J Pers Med       Date:  2022-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.